Insider Trading activities of Iterum Therapeutics Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iterum Therapeutics Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Iterum Therapeutics Plc since year 2005. Table 2 shows the detailed insider transactions of Iterum Therapeutics Plc since 2005. The reporting company's ticker symbol is ITRM. The reporting company's CIK number is 1659323.
The total value of stock buying since 2005 is $57,372,989.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Iterum Therapeutics Plc (ITRM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-11 10,000 $62,890 0 $0 0 $0
2018-10 58,000 $353,800 0 $0 0 $0
2018-09 500 $5,000 0 $0 0 $0
2018-08 3,500 $32,684 0 $0 0 $0
2018-05 4,378,355 $56,918,615 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Iterum Therapeutics Plc insiders (ITRM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-11-30 Kelly David George (Director) Buy 10,000 6.29 62,890
2018-10-30 Chin Mark (Director) Buy 58,000 6.10 353,800
2018-09-04 Dunne Michael W. (Chief Scientific Officer) Buy 500 10.00 5,000
2018-08-27 Dunne Michael W. (Chief Scientific Officer) Buy 500 10.00 5,000
2018-08-24 Dunne Michael W. (Chief Scientific Officer) Buy 500 10.00 5,000
2018-08-23 Edick Paul R (Director) Buy 500 10.44 5,218
2018-08-17 Fishman Corey N. (President & CEO) Buy 2,000 8.73 17,466
2018-05-30 Chin Mark (Director) Buy 337,606 13.00 4,388,878
2018-05-30 Matthews Judith M. (Chief Financial Officer) Buy 4,000 13.00 52,000
2018-05-30 Canaan Partners X Llc (Director) Buy 506,656 13.00 6,586,528
2018-05-30 Fhm Vii, L.p. (10% Owner) Buy 456,099 13.00 5,929,287
2018-05-30 Mehra Anand Buy 500,000 13.00 6,500,000
2018-05-30 Fishman Corey N. (President & CEO) Buy 3,000 13.00 39,000
2018-05-30 Dunne Michael W. (Chief Scientific Officer) Buy 2,000 13.00 26,000
2018-05-30 Ratcliffe Liam (10% Owner) Buy 662,677 13.00 8,614,801
2018-05-30 Malik Shahzad (Director) Buy 236,984 13.00 3,080,792
2018-05-30 Ahrens Brenton Karl (Director) Buy 506,656 13.00 6,586,528
2018-05-30 Hunt Ronald (Director) Buy 662,677 13.00 8,614,801
2018-05-30 Healy James (Director) Buy 500,000 13.00 6,500,000

Insider trading activities including stock purchases, stock sales, and option exercises of ITRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Iterum Therapeutics Plc (symbol ITRM, CIK number 1659323) see the Securities and Exchange Commission (SEC) website.